[1]
“IN-VITRO EFFICACY OF PIPERACILLIN/SULBACTAM AGAINST MULTIDRUG-RESISTANT PSEUDOMONAS AERUGINOSA: A COMPARATIVE STUDY WITH PIPERACILLIN/TAZOBACTAM AND CEFOPERAZONE/SULBACTAM”, FMHR, vol. 4, no. 3, pp. 4971–4977, Mar. 2026, Accessed: Nov. 08, 2026. [Online]. Available: https://fmhr.net/index.php/fmhr/article/view/3904